NEAT1 as a competing endogenous RNA in tumorigenesis of various cancers: Role, mechanism and therapeutic potential

Int J Biol Sci. 2021 Aug 3;17(13):3428-3440. doi: 10.7150/ijbs.62728. eCollection 2021.

Abstract

The nuclear paraspeckle assembly transcript 1 (NEAT1) is a long non-coding RNA (lncRNA) that is upregulated in a variety of human cancer types. Increasing evidence has shown that the elevation of NEAT1 in cancer cells promotes cell growth, migration, and invasion and inhibits cell apoptosis. It is also known that lncRNAs act as a competing endogenous RNA (ceRNA) by sponging microRNAs (miRNAs) to alter the expression levels of their target genes in the development of cancers. Therefore, it is important to understand the molecular mechanisms underlying this observation. In this review, specific emphasis was placed on NEAT1's role in tumor development. We also summarize and discuss the feedback roles of NEAT1/miRNA/target network in the progression of various cancers. As our understanding of the role of NEAT1 during tumorigenesis improves, its therapeutic potential as a biomarker and/or target for cancer also becomes clearer.

Keywords: NEAT1; cancer; competing endogenous RNA; long non-coding RNA; microRNA; therapeutic target.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Carcinogenesis*
  • Gene Expression Regulation, Neoplastic*
  • Humans
  • Neoplasms / metabolism*
  • RNA, Long Noncoding / metabolism*

Substances

  • NEAT1 long non-coding RNA, human
  • RNA, Long Noncoding